Form 4 for OPRX OptimizeRx Corp
Accepted 2026-06-10 13:18:04 ET · period of report 2026-05-01 · accession 0001628280-26-042124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 13:18 | 2026-05-01 | OPRX | Presti Mariyamma Varghese | Dir | A - Grant | $0.00 | +13.1K | 13.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 13,060 | $0.00 | 13,060 | D | — | — | (F1) Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the first anniversary of the date of the grant. |